Search Results

Instead of creating another black-box assay, they designed pHSense around rare-earth europium probes. The Chemistry That Almost Didn’t Work Designing pH-sensitive rare-earth complexes was not an obvious

discovery has the potential to accelerate the identification and development of novel drugs, optimize drug design compared; and 3) detection, prediction, or generation (e.g. prediction of a protein structure, or ligand design De novo drug design: AI algorithms can generate new molecules with desired properties, such as binding Multi-target drug design: GPCRs are often involved in complex signaling networks. With the revolution of biased signalling of GPCRs comes the possibility of designing drugs that selectively

Structure-based design  powered by cryo-EM and AI. 🔬 Inside the GPCR Track Agenda Expect deep dives is more than an academic experience — it’s like being handed a new set of tools to rethink your drug design

Rock your favorite design, spark conversations in the lab, and help power everything we build—one mug

It’s about finding purpose through loss, choosing academia when many peers walk away, and designing science potencies in seized samples, drug combinations that mirror contamination patterns, and experimental designs

Some innovative solutions have been the development of the BERKY and the ONE-GO biosensors, designed The ONE-GO biosensors, designed in a single vector, incorporate a G protein tagged with a YFP acceptor M., et al., Revealing the Activity of Trimeric G-proteins in Live Cells with a Versatile Biosensor Design

That meant simulations, ligand screening, and experimental design could move forward with confidence.

crystallography and cryo-EM have resulted in a wealth of GPCR structures that have been used in drug design

Startups Play by Different Rules — and Most Scientific Founders Miss That   A research lab is designed A startup is designed for progress.

GPCR Foundry  — our R&D and biotech hub designed to bridge GPCR science with execution. The Dr. GPCR Retreat  — our largest in-person event yet, designed to bring together scientists, industry leaders

molecular insights into the functions and regulation of B2R, which shed light on structure-based drug design

orphan GPCR strategies; and advances across nanodiscs, peptidiscs, SMALPs, SPR, ITC—plus how construct design Members-only networking, AMAs & matchmaking 💡 Support open resources for the global GPCR field 🧠 Designed

With the United States Food and Drug Administration's designation of psilocybin as a "Breakthrough Therapy

do not reveal a clear conformational basis for signaling bias, which would have enabled the rational design

Engineered G protein-coupled receptors (GPCRs) are commonly used in chemogenetics as designer receptors exclusively activated by designer drugs (DREADDs).

side effects, and tools to explore the ORs nature and function, various (poly)pharmacological ligand design

Structure-guided design of a peripherally restricted chemogenetic system Hye Jin Kang , Brian E Krumm effective in relapsed myeloma after CAR T-cell therapy Methods & Updates in GPCR Research Structure-guided design

A detailed analysis of the engagements allows us to design mutations that specifically enhance one pathway

Here, we provide guidelines and terminology for any scientists to design and report ligand bias experiments

Thus, rational design using efficient synthetic strategies is needed to make these probes as specific Our scientific team can guide you choose or design the right fluorescent ligand for your research.  

It can inform decisions in drug design, improving therapeutic outcomes and reducing unwanted side effects

Here, we address this shortcoming by exploring different fusion protein designs, which lead to structures

Tirzepatide's success underscores the potential of designing drugs that selectively target beneficial basis of biased agonism continues to grow, it is likely to play an increasingly important role in the design

provides fresh insights into the mechanistic details of class C GPCRs activation expected to be useful for designing

understand the basis of the ligand preferences of the receptors and to assist structure-based drug design

findings fill a gap in the understanding of CB1 allosteric regulation and could guide the rational design

the identification of allosteric sites as well as ligand-based and structure-based drug discovery and design

reported intracellular CCR2 antagonists, several tetramethylrhodamine (TAMRA)-labeled CCR2 ligands were designed

They design assays differently. They interpret deviations differently. Kenakin  noted, it wasn’t designed.

GPCR that may provide a new venue for highly specific modulation of GPCR function and advanced drug design